MANZAR RAJPUT: Open Payments
NPI 1851358527 · FARMINGTON HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$264,517 in 394 payments from 12 companies in 2025. Trend: 2023 $94,047 · 2024 $214,161 · 2025 $264,517
Speaker / faculty: $165,849Honoraria: $64,450Consulting: $14,245Travel & lodging: $10,541Food & beverage: $9,333Education: $100
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 91 | $69,602 |
| ABBVIE INC. | 90 | $60,799 |
| Teva Pharmaceuticals USA, Inc. | 56 | $59,961 |
| E.R. Squibb & Sons, L.L.C. | 79 | $53,770 |
| Alkermes, Inc. | 34 | $19,416 |
| Neurocrine BioSciences, Inc. | 15 | $336 |
| Otsuka America Pharmaceutical, Inc. | 10 | $230 |
| Lundbeck LLC | 10 | $198 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| Janssen Pharmaceuticals, Inc | 2 | $59 |
Products named: Auvelity, VRAYLAR, UZEDY, COBENFY, LYBALVI, REXULTI, INGREZZA, ARISTADA.
Industry payments across MI — which companies pay providers there.
